Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
ETFs
Etats-Unis
AMEX
Meet Kevin Pricing Power ETF (PP)
Meet Kevin Pricing Power ETF (PP) Actualités

PP

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:PP

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/10/2008	19h03	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	AMEX:PP	Meet Kevin Pricing Power ETF
06/10/2008	14h30	Marketwired	Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th	AMEX:PP	Meet Kevin Pricing Power ETF
19/09/2008	14h30	Marketwired	Pipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and Re	AMEX:PP	Meet Kevin Pricing Power ETF
29/08/2008	23h01	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)	AMEX:PP	Meet Kevin Pricing Power ETF
19/08/2008	14h54	Marketwired	Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis	AMEX:PP	Meet Kevin Pricing Power ETF
19/08/2008	14h30	Marketwired	Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City	AMEX:PP	Meet Kevin Pricing Power ETF
14/08/2008	22h49	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)	AMEX:PP	Meet Kevin Pricing Power ETF
14/08/2008	22h18	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
14/08/2008	19h39	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
12/08/2008	14h27	Marketwired	Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference	AMEX:PP	Meet Kevin Pricing Power ETF
15/07/2008	14h40	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:PP	Meet Kevin Pricing Power ETF
15/07/2008	00h45	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:PP	Meet Kevin Pricing Power ETF
09/07/2008	14h38	Marketwired	Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Or	AMEX:PP	Meet Kevin Pricing Power ETF
08/07/2008	21h54	Marketwired	Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry	AMEX:PP	Meet Kevin Pricing Power ETF
08/07/2008	13h41	Marketwired	Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer	AMEX:PP	Meet Kevin Pricing Power ETF
20/05/2008	15h00	Marketwired	Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules	AMEX:PP	Meet Kevin Pricing Power ETF
15/05/2008	22h36	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
13/05/2008	15h05	Marketwired	Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15	AMEX:PP	Meet Kevin Pricing Power ETF
12/05/2008	15h23	Marketwired	Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)	AMEX:PP	Meet Kevin Pricing Power ETF
07/05/2008	15h00	Marketwired	Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease	AMEX:PP	Meet Kevin Pricing Power ETF
29/04/2008	21h35	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
21/04/2008	14h02	Marketwired	Pipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for Fibromyalgia	AMEX:PP	Meet Kevin Pricing Power ETF
18/04/2008	23h13	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
31/03/2008	22h41	Marketwired	Pipex Pharmaceuticals Announces Fourth Quarter and Year End 2007 Results	AMEX:PP	Meet Kevin Pricing Power ETF
11/03/2008	12h24	Marketwired	Pipex Pharmaceuticals Announces Cost Reduction Measures	AMEX:PP	Meet Kevin Pricing Power ETF
10/03/2008	15h06	Marketwired	CORRECTION: Pipex Pharmaceuticals' Oral Flupirtine IND With FDA for Phase II Clinical Trial for Fibromyalgia Not Yet Open	AMEX:PP	Meet Kevin Pricing Power ETF
10/03/2008	13h15	Marketwired	Pipex Pharmaceuticals' Oral Flupirtine Opens IND With FDA for Phase II Clinical Trial for Fibromyalgia	AMEX:PP	Meet Kevin Pricing Power ETF
29/02/2008	13h00	Marketwired	Pipex Pharmaceuticals Completes Type A Meeting With FDA for Oral Tetrathiomolybdate New Drug Application	AMEX:PP	Meet Kevin Pricing Power ETF
13/02/2008	23h05	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A)	AMEX:PP	Meet Kevin Pricing Power ETF
31/01/2008	15h24	Marketwired	Pipex Pharmaceuticals Announces First Notice of Allowance for U.S. Patent Covering Uses of Low Potency Bioidentical Estrogens fo	AMEX:PP	Meet Kevin Pricing Power ETF